基于TOPSIS法的临床路径效果评价  

Effect Evaluation on Clinical Pathway by Using TOPSIS

作　　者：杨炯[1] 邵新华[1] 徐卫国[1] 

机构地区：[1]上海交通大学医学院附属新华医院,上海200092

出　　处：《中国卫生质量管理》2013年第2期31-33,共3页Chinese Health Quality Management

基　　金：上海卫生局科研项目(项目批准号:2010062)

摘　　要：通过对上海市某三级医院白内障人工晶体植入术患者临床路径组和对照组的住院时间、检查项目费用、药物费用、床日费用、视力改善情况、术后并发症情况等的比较,运用TOPSIS法对临床路径实施效果进行综合评价。结果显示,实施临床路径前后的检查费用和手术费用没有差异;药物费用、住院床日费用和住院总费用则显著降低(P<0.05);平均住院天数由4天降低到3天;术眼视力在术后得到明显改善,两组在并发症和治愈率上无明显差异。临床路径组患者的综合效果均好于对照组。Based on the comparison between clinical pathway group and control group in a tertiary hospital in Shanghai, a comprehensive effect evaluation was performed by using TOPSIS on clinical pathway of cataract intraocular lens implantation. The comparison factors include length of stay, cost of clinical tests, drug costs, bed cost per day, improvement in visual acuity, and postoperative complications, etc. Findings exhibited no differences in cost of clinical tests and cost of surgery between the two groups. Pharmacy cost, bed cost per day and total costs of hospitalization were much lower in the conservation group than those in the control group （ P 〈 0.05 ） . Average length of stay decreased from 4 days to 3 days. Eyesight improved significantly after surgery in both groups. There were no significant difference in complications and cure rates. The clinical pathway group showed better comprehensive effect than the control group.

关 键 词：临床路径 评价 TOPSIS 

分 类 号：R195.1[医药卫生—卫生统计学]